Group One Trading’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1,000K | Buy |
+122,827
| New | +$1,000K | ﹤0.01% | 496 |
|
|
2025
Q1 | – | Sell |
-4,114
| Closed | -$61.3K | – | 3261 |
|
|
2024
Q4 | $61.3K | Sell |
4,114
-153,919
| -97% | -$2.29M | ﹤0.01% | 1174 |
|
|
2024
Q3 | $2.42M | Buy |
158,033
+134,264
| +565% | +$2.05M | 0.01% | 230 |
|
|
2024
Q2 | $362K | Sell |
23,769
-51,071
| -68% | -$778K | ﹤0.01% | 532 |
|
|
2024
Q1 | $1.41M | Buy |
74,840
+18,470
| +33% | +$349K | 0.01% | 260 |
|
|
2023
Q4 | $1.08M | Sell |
56,370
-16,770
| -23% | -$320K | ﹤0.01% | 369 |
|
|
2023
Q3 | $1.31M | Sell |
73,140
-23,326
| -24% | -$419K | ﹤0.01% | 329 |
|
|
2023
Q2 | $1.96M | Buy |
+96,466
| New | +$1.96M | 0.01% | 222 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2933 |
|
|
2022
Q4 | – | Sell |
-5,833
| Closed | -$153K | – | 2980 |
|
|
2022
Q3 | $153K | Sell |
5,833
-12,602
| -68% | -$331K | ﹤0.01% | 909 |
|
|
2022
Q2 | $467K | Buy |
+18,435
| New | +$467K | ﹤0.01% | 639 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2999 |
|
|
2021
Q4 | – | Sell |
-228
| Closed | -$8K | – | 3084 |
|
|
2021
Q3 | $8K | Buy |
+228
| New | +$8K | ﹤0.01% | 1867 |
|
|
2021
Q2 | – | Sell |
-1,108
| Closed | -$31K | – | 2858 |
|
|
2021
Q1 | $31K | Buy |
1,108
+845
| +321% | +$23.6K | ﹤0.01% | 1475 |
|
|
2020
Q4 | $7K | Buy |
+263
| New | +$7K | ﹤0.01% | 1446 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2288 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2104 |
|